Importantly, animals injected with CD79a-KO cells showed a highly significant median survival prolongation of 66 days compared to mice injected with CD79a-Ctr cells (29 days vs. 95 days, Fig. 2g ).
← all excerpts
CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia.
1
—
—